Relapsing polychondritis-like ear disease responding to etanercept in two patients with psoriasis and psoriatic arthritis - 10/08/11
![](/templates/common/images/mail.png)
![](/templates/common/images/entites/lowast.gif)
Funding sources: Both patients are parts of phase IV clinical trials of etanercept and the drugs were provided by Wyeth Pharmaceuticals, Collegeville, PA. |
|
Conflicts of interest: Dr Tsai has conducted clinical trials for etanercept and received honoraria for serving as a consultant for Wyeth Pharmaceuticals. Dr Lee has no conflicts of interest to disclose. |
Vol 64 - N° 5
P. 1006-1007 - mai 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?